The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Atreca, Inc(PINK:BCEL) 
Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery...
Website: http://www.atreca.com
Founded: 2010
IPO Price: $17 (Jun 20, 2019)
Full Time Employees: 128
CEO: John A. Orwin
Sector: Healthcare
Industry: Biotechnology
Atreca Days Payable Outstanding ttm (DPO)
Atreca Days Receivable Outstanding ttm (DSO)
Atreca Days Inventory Outstanding ttm (DIO)
Atreca Op Cashflow Per Share ttm
Atreca Free Cashflow Per Share ttm
Atreca Cash Per Share ttm
Atreca P/S ratio ttm
Atreca (GAAP) P/E ratio ttm
Atreca P/B ratio ttm
No extra charts and metrics for this ticker.